Ask Ruby: What is KRAS?

preview_player
Показать описание
Ruby, your virtual community navigator, will help explain what you need to know about the biomarker "KRAS" and how it can impact cancer treatment.

  1. Cancer Support Community
Рекомендации по теме
Ask Ruby: What 0:01:48

Ask Ruby: What is KRAS?

KRAS Driven Cancers 0:00:41

KRAS Driven Cancers (KRAS episode 2)

Ask Ruby: What 0:01:33

Ask Ruby: What Patients Need to Know About Step Therapy

The beating heart 0:00:46

The beating heart of cancer (KRAS episode 1)

KRAS Mutations in 0:06:52

KRAS Mutations in Solid Tumors

An Overview of 0:04:10

An Overview of KRAS Tumor Biology

Treating KRAS G12C 0:01:42

Treating KRAS G12C Mutations

Advances in the 0:01:27

Advances in the development of KRAS inhibitors

Unmet needs in 0:00:41

Unmet needs in KRAS-driven non-small cell lung cancer

Survival Differences in 0:01:43

Survival Differences in KRAS/BRAF Mutations in mCRC

We're Finally Beginning 0:04:46

We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer

Mitigating resistance in 0:05:16

Mitigating resistance in KRAS-driven cancers

Marwan G. Fakih, 0:01:14

Marwan G. Fakih, MD, on whether KRAS amplification predicts resistance to EGFR therapies

Treatment strategies for 0:01:37

Treatment strategies for KRAS-mutant NSCLC with co-mutations

Testing for KRAS 0:06:30

Testing for KRAS Mutations in NSCLC

Challenges of KRAS-targeting 0:01:25

Challenges of KRAS-targeting for lung cancer therapy

Dr. Skoulidis and 1:56:56

Dr. Skoulidis and Terri Conneran Discuss Treatment Strategy for Lung, Colon, and Pancreatic Cancers

Improving outcomes in 0:00:41

Improving outcomes in KRAS-mutant pancreatic cancer

The role of 0:00:47

The role of immunotherapy with KRAS inhibitors in KRAS-driven NSCLC

The Role of 0:03:03

The Role of KRas in Cancer

KRAS Mutation Subtypes 0:05:57

KRAS Mutation Subtypes in Advanced NSCLC

Personalized treatment approaches 0:00:51

Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer

Real-world outcomes by 0:05:14

Real-world outcomes by co-mutation status in KRAS G12C-mutant NSCLC

KRAS Colon Cancer 0:00:19

KRAS Colon Cancer FBSTORY